Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Germany / NCT06648733
Recruiting Not applicable

Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care

NCT06648733 · tracked via the Priya Life Science Germany tracker
Sponsor
University Hospital Muenster
Phase
Not applicable
Started
2024-06-20
Last updated
2025-06-13

Condition(s) studied

CancerHeart FailureCOPD

Investigational drug(s) / intervention(s)

Structured pharmaceutical discharge management

Structured pharmaceutical discharge management: These patients will receive structured pharmaceutical discharge management from inpatient to outpatient care.

Study summary

The transition of palliative care patients from inpatient to outpatient care is aimed to be improved through structured pharmaceutical discharge management by a trained pharmacist. This data will be compared with retrospective cases.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: All individual indications for general and specialised palliative care as part of routine clinical practice (e.g.): * advanced, malignant tumour disease * advanced, chronic obstructive pulmonary disease * Patients with advanced disease and limited life expectancy (approx. 12 months) Further care in the SOPC Muenster (prospective data) Sufficient understanding of the German language to be able to understand the information and consent form Exclusion Criteria: Impossibility of understanding the information and declaration of consent.

Primary outcome measure(s)

  • (I) Drug-related problems — 12 months
    (I) Number of drug-related problems at the time of discharge according to PCNE (comparison of prospective, actually proposed changes vs. hypothetical number and type of problems at the time of discharge in the retrospective comparison cohort)
  • (II) Drug-related problems — 12 months
    (II) Type of drug-related problems at the time of discharge according to PCNE (comparison of prospective, actually proposed changes vs. hypothetical number and type of problems at the time of discharge in the retrospective comparison cohort)

Trial sites (1)

FacilityCityRegionStatus
University Hospital Muenster Münster North Rhine-Westphalia Recruiting

More University Hospital Muenster trials in Germany

Breast Cancer Screening: Digital Breast Tomosynthesis Versus Digital 2D Mammography Active, not recruiting
Filter Lifespan in Continuous Renal Replacement Therapy Recruiting
Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents Active, not recruiting
International Primary Ciliary Dyskinesia (PCD) Registry Recruiting
Biomechanical Effects of EMST® on Swallowing Function in Parkinson's Disease Recruiting

Other trials for the same condition

Aeson TAH System - Post-Market Clinical Follow-up Study Recruiting
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION Recruiting
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity Recruiting
Optimization of Radiation Protection Through Genomic Analyses Recruiting
Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure (HF) in Germany Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06648733 on ClinicalTrials.gov ↗ ← All trials in Germany